Infection and Drug Resistance's 2026 Journal Metrics Score is 2.6, ranking Q2 in Infectious Diseases and 2 other subfields. Two-year citation average from OpenAlex data, updated August 2026.
Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.
Journal Metrics Score 2026 · 2021–2024 window citedness 3.50.
Middle 50%: 79–128 days
100 of 100 PubMed-indexed articles · 100% coverage · 2024–2025
Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.
Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.
Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.
Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.
358 of 2,554 works · same type, year & subfield
25 works · same type, year & subfield
Below field-year expectation
of 3,419 topic-associated OpenAlex sources by lifetime output
FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.93, so its typical recent paper runs about 7% below its field benchmark.
14% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.
Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.
OpenAlex source records · 2016–2025
2,554 OpenAlex works · 2021–2024
OpenAlex topics show the research communities this journal serves.
Candidates share at least one OpenAlex subfield (or field, if too few do) with this journal's main research topics, ignoring generic catch-all topics, and are ordered by topic overlap, then current Journal Metrics Score.
* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.
| Category | Quartile |
|---|---|
| Molecular Medicine | Q3 |
| Infectious Diseases | Q2 |
| Clinical Biochemistry | Q2 |
| Applied Microbiology and Biotechnology | Q2 |
Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.
Infection and Drug Resistance's 2026 Journal Metrics Score is 2.6, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.
Infection and Drug Resistance's best quartile is Q2. By OpenAlex subfield: Q3 in Molecular Medicine; Q2 in Infectious Diseases; Q2 in Clinical Biochemistry; Q2 in Applied Microbiology and Biotechnology. Quartiles rank journals by Journal Metrics Score within each subfield.
No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Infection and Drug Resistance will not match this score exactly. Compare journals using one source at a time.
Across 100 recent PubMed records with both dates, Infection and Drug Resistance took a median of 103 days from submission to acceptance; the middle half took 79–128 days. This interval includes editorial handling and revisions, so it is not the time to a first decision.
OpenAlex lists an indicative article processing charge of $2,836 USD for Infection and Drug Resistance. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.
Comparable journals include Annals of Clinical Microbiology and Antimicrobials, International Journal of Antimicrobial Agents, Clinical Microbiology Reviews, and Npj Antimicrobials and Resistance. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.